Publications
5600 Results
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 3517); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- C89803
Nut consumption and survival in stage III colon cancer patients: results from CALGB 89803 (Alliance)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 3516); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Analysis of serum vitamin D levels and prognosis in stage III colon carcinoma patients treated with adjuvant FOLFOX+/- cetuximab chemotherapy: NCCTG N0147 (Alliance)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 3579); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Association of immune markers and immunoscore with survival of stage III colon cancer (CC) patients treated with adjuvant FOLFOX: NCCTG N0147 (Alliance)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 3604); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Genetic correlates of therapeutic toxicities of stage III colon cancer patients treated with adjuvant FOLFOX+/-cetuximab (NCCTG N0147, Alliance)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 5019); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9921
Adjuvant androgen deprivation (AD) +mitoxantrone + prednisone (MP) in high risk prostate cancer (PC) patients post radical prostatectomy (RP): phase III intergroup trial S9921
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 4566); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0931
Everolimus (EVE) exposure as a predictor of toxicity in renal cell cancer (RCC) patients (pts) in the adjuvant setting: results of pharmacokinetic analysis initial results for from SWOG S0931 (EVEREST), a phase III study (ClinicalTrials.gov Identifier:NCT01120249).
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr TPS4596);American Society of Clinical Oncology (ASCO) Annual Meeting (June 2-6, 2017, Chicago, IL), poster session (TIP)
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/EA8143
A phase 3 randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC, EA8143)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr TPS4599); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1500
A randomized, phase II efficacy assessment of multiple MET kinase inhibitors (Cabozantinib [NSC #761968], crizotinib [NSC #749005], savolitinib [NSC #785348], and sunitinib [NSC #736511]) in metastatic papillary renal carcinoma (PAPMET): SWOG S1500, NCT02761057
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr TPS4591); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1605
SWOG S1605: phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer
- Journal / Conference
- Canadian Urological Association Journal June Vol 11(6Suppl4): abst. MP-04.15; Canadian Urological Association annual meeting (June 24-27, 2017, Toronto, Ontario, Canada), poster
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1605